Grant funds to translate imaging technologies for better understanding of cancer and disease biology, diagnosis, and treatment.
Funder: National Institutes of Health
Due Dates: January 7, 2027 (Closing date for applications)
Funding Amounts: $500,000 award ceiling; less than $500,000 in direct costs per year; up to 5 years
Summary: Supports academic-industrial partnerships translating and validating imaging, data science, and spectroscopic technologies for cancer and other disease-related problems.
Key Information: Teams must include at least one academic investigator and one industrial investigator as key members.
The National Cancer Institute (NCI) supports translational research through this R01 program, bringing academic and industrial investigators together to advance imaging, data science, and spectroscopic technologies. Projects should move technologies with demonstrated feasibility toward optimization and validation, delivering new capabilities to end users. Applications may address clinical research, clinical care delivery, or non-clinical research, including non-human cancer imaging without an immediate prospect of clinical use.
Supported work includes quantitative and multimodal imaging, contrast agents and probes, image-guided interventions, surgical imaging, near-real-time tissue analysis, and computational methods such as machine learning. Improvements may target reproducibility, reliability, speed, usability, affordability, or performance across platforms and sites. Clinical trials are optional and may test functionality or validate performance when translation is their primary motivation.